引言当癌症的阴霾笼罩，当一次次治疗宣告失败，希望似乎变得遥不可及。对于许多罹患CD30阳性（CD30+）淋巴瘤，特别是霍奇金淋巴瘤（Hodgkin Lymphoma, HL）的患者而言，如果连靶向药物维布妥昔单抗（Brentuximab ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...